Steward Partners Investment Advisory’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.6M | Buy |
25,607
+4,062
| +19% | +$2.2M | 0.06% | 283 |
|
|
2025
Q4 | $12.5M | Buy |
21,545
+1,533
| +8% | +$867K | 0.07% | 254 |
|
|
2025
Q3 | $9.71M | Sell |
20,012
-2,226
| -10% | -$1.04M | 0.06% | 286 |
|
|
2025
Q2 | $9.02M | Sell |
22,238
-10,925
| -33% | -$4.57M | 0.07% | 275 |
|
|
2025
Q1 | $16.5M | Buy |
33,163
+414
| +1% | +$224K | 0.15% | 143 |
|
|
2024
Q4 | $17M | Sell |
32,749
-1,145
| -3% | -$630K | 0.15% | 132 |
|
|
2024
Q3 | $21M | Buy |
33,894
+271
| +0.8% | +$160K | 0.19% | 111 |
|
|
2024
Q2 | $18.6M | Buy |
33,623
+341
| +1% | +$195K | 0.2% | 104 |
|
|
2024
Q1 | $19.3M | Buy |
33,282
+1,556
| +5% | +$873K | 0.21% | 96 |
|
|
2023
Q4 | $16.8M | Sell |
31,726
-1,005
| -3% | -$486K | 0.23% | 89 |
|
|
2023
Q3 | $16.6M | Buy |
32,731
+729
| +2% | +$388K | 0.25% | 85 |
|
|
2023
Q2 | $16.7M | Sell |
32,002
-401
| -1% | -$216K | 0.25% | 88 |
|
|
2023
Q1 | $18.7M | Sell |
32,403
-909
| -3% | -$512K | 0.3% | 77 |
|
|
2022
Q4 | $18.3M | Buy |
33,312
+3,165
| +10% | +$1.68M | 0.31% | 74 |
|
|
2022
Q3 | $15.3M | Sell |
30,147
-999
| -3% | -$559K | 0.29% | 77 |
|
|
2022
Q2 | $16.9M | Sell |
31,146
-1,623
| -5% | -$893K | 0.31% | 75 |
|
|
2022
Q1 | $19.4M | Buy |
32,769
+792
| +2% | +$455K | 0.3% | 73 |
|
|
2021
Q4 | $21.3M | Buy |
31,977
+8,914
| +39% | +$5.57M | 0.32% | 67 |
|
|
2021
Q3 | $13.2M | Sell |
23,063
-1,759
| -7% | -$965K | 0.23% | 104 |
|
|
2021
Q2 | $12.5M | Sell |
24,822
-3,415
| -12% | -$1.61M | 0.21% | 106 |
|
|
2021
Q1 | $12.9M | Buy |
28,237
+2,532
| +10% | +$1.21M | 0.23% | 105 |
|
|
2020
Q4 | $12M | Buy |
25,705
+1,106
| +4% | +$519K | 0.26% | 99 |
|
|
2020
Q3 | $10.9M | Buy |
24,599
+8,714
| +55% | +$3.6M | 0.27% | 89 |
|
|
2020
Q2 | $5.76M | Sell |
15,885
-4,061
| -20% | -$1.36M | 0.16% | 151 |
|
|
2020
Q1 | $5.66M | Sell |
19,946
-3,109
| -13% | -$980K | 0.21% | 120 |
|
|
2019
Q4 | $7.49M | Buy |
23,055
+1,075
| +5% | +$326K | 0.22% | 108 |
|
|
2019
Q3 | $6.4M | Buy |
21,980
+3,346
| +18% | +$958K | 0.22% | 113 |
|
|
2019
Q2 | $5.47M | Buy |
18,634
+2,186
| +13% | +$602K | 0.2% | 121 |
|
|
2019
Q1 | $4.5M | Sell |
16,448
-3,404
| -17% | -$847K | 0.19% | 123 |
|
|
2018
Q4 | $4.44M | Buy |
19,852
+2,377
| +14% | +$558K | 0.22% | 112 |
|
|
2018
Q3 | $4.26M | Sell |
17,475
-9,735
| -36% | -$2.24M | 0.2% | 119 |
|
|
2018
Q2 | $5.64M | Buy |
27,210
+1,284
| +5% | +$273K | 0.34% | 71 |
|
|
2018
Q1 | $5.35M | Buy |
25,926
+1,524
| +6% | +$320K | 0.37% | 62 |
|
|
2017
Q4 | $4.63M | Buy |
24,402
+15,763
| +182% | +$3.02M | 0.35% | 69 |
|
|
2017
Q3 | $1.63M | Sell |
8,639
-255
| -3% | -$46.2K | 0.17% | 132 |
|
|
2017
Q2 | $1.55M | Buy |
8,894
+10
| +0.1% | +$1.68K | 0.17% | 131 |
|
|
2017
Q1 | $1.36M | Buy |
8,884
+4,383
| +97% | +$670K | 0.21% | 105 |
|
|
2016
Q4 | $635K | Buy |
+4,501
| New | +$664K | 0.29% | 84 |
|
Other funds holding TMO
VCM
Steward Partners Investment Advisory's TMO Position: Q1 2026 in Review
Steward Partners Investment Advisory increased its Thermo Fisher Scientific (TMO) stake by 19% in Q1 2026, buying an estimated $2.2M and bringing the position to 25,607 shares worth $12.6M. The position accounts for 0.06% of the portfolio, ranked #283.
Steward Partners Investment Advisory first reported a position in TMO in Q4 2016 and has held it in 38 quarters since. The position peaked at $21.3M in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Steward Partners Investment Advisory held 25,607 shares of Thermo Fisher Scientific worth $12.6M as of Q1 2026.
- Steward Partners Investment Advisory bought 4,062 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.2M.
- Thermo Fisher Scientific made up 0.06% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #283 holding.
- Steward Partners Investment Advisory first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 38 quarters since.
- Steward Partners Investment Advisory's Thermo Fisher Scientific position peaked at $21.3M in Q4 2021.
- 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.